• News
  • BioTech

Senhwa Biosciences raises $17M Series B financing

Senhwa Biosciences Inc.a new drug development company registered in Taiwan with operations in Taiwan and San Diego, has raised an additional $17 million in a Series B financing to drive its anticancer agents through critical clinical trials.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!